150 related articles for article (PubMed ID: 10362085)
21. Detection of human papillomavirus DNA sequences in oral squamous cell carcinomas and their relation to p53 and proliferating cell nuclear antigen expression.
Shindoh M; Chiba I; Yasuda M; Saito T; Funaoka K; Kohgo T; Amemiya A; Sawada Y; Fujinaga K
Cancer; 1995 Nov; 76(9):1513-21. PubMed ID: 8635051
[TBL] [Abstract][Full Text] [Related]
22. Pathological features of betel quid-related oral epithelial lesions in taiwan with special emphasis on the tumor progression and human papillomavirus association.
Chang KC; Su IJ; Tsai ST; Shieh DB; Jin YT
Oncology; 2002; 63(4):362-9. PubMed ID: 12417791
[TBL] [Abstract][Full Text] [Related]
23. Co-expression of low-risk HPV E6/E7 and EBV LMP-1 leads to precancerous lesions by DNA damage.
Uehara K; Tanabe Y; Hirota S; Higa S; Toyoda Z; Kurima K; Kina S; Nakasone T; Arasaki A; Kinjo T
BMC Cancer; 2021 Jun; 21(1):688. PubMed ID: 34112111
[TBL] [Abstract][Full Text] [Related]
24. TGF-beta-mediated cell cycle arrest of HPV16-immortalized human ectocervical cells correlates with decreased E6/E7 mRNA and increased p53 and p21(WAF-1) expression.
Rorke EA; Zhang D; Choo CK; Eckert RL; Jacobberger JW
Exp Cell Res; 2000 Aug; 259(1):149-57. PubMed ID: 10942587
[TBL] [Abstract][Full Text] [Related]
25. Expression of p53, cyclin D1 and Ki-67 in pre-malignant and malignant oral lesions: association with clinicopathological parameters.
Raju B; Mehrotra R; Oijordsbakken G; Al-Sharabi AK; Vasstrand EN; Ibrahim SO
Anticancer Res; 2005; 25(6C):4699-706. PubMed ID: 16334163
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of high-risk human papilloma virus types and its association with P53 codon 72 polymorphism in tobacco addicted oral squamous cell carcinoma (OSCC) patients of Eastern India.
Nagpal JK; Patnaik S; Das BR
Int J Cancer; 2002 Feb; 97(5):649-53. PubMed ID: 11807792
[TBL] [Abstract][Full Text] [Related]
27. Analysis of p53, p16(INK4a), pRb and Cyclin D1 expression and human papillomavirus in primary ovarian serous carcinomas.
Bilyk OO; Pande NT; Buchynska LG
Exp Oncol; 2011 Sep; 33(3):150-6. PubMed ID: 21956468
[TBL] [Abstract][Full Text] [Related]
28. "High risk" HPV types are frequently detected in potentially malignant and malignant oral lesions, but not in normal oral mucosa.
Bouda M; Gorgoulis VG; Kastrinakis NG; Giannoudis A; Tsoli E; Danassi-Afentaki D; Foukas P; Kyroudi A; Laskaris G; Herrington CS; Kittas C
Mod Pathol; 2000 Jun; 13(6):644-53. PubMed ID: 10874669
[TBL] [Abstract][Full Text] [Related]
29. Infection of human papillomavirus (HPV) and p53 over-expression in human female genital tract carcinoma.
Anwar K; Nakakuki K; Imai H; Shiraishi T; Inuzuka M
J Pak Med Assoc; 1996 Oct; 46(10):220-4. PubMed ID: 8961706
[TBL] [Abstract][Full Text] [Related]
30. Human papillomavirus infection in oral verrucous carcinoma: genotyping analysis and inverse correlation with p53 expression.
Fujita S; Senba M; Kumatori A; Hayashi T; Ikeda T; Toriyama K
Pathobiology; 2008; 75(4):257-64. PubMed ID: 18580072
[TBL] [Abstract][Full Text] [Related]
31. Detection of p53 protein and Ki-67 proliferation antigen in human papillomavirus (HPV)-positive and HPV-negative cervical lesions by immunohistochemical double-staining.
Tervahauta AI; Syrjänen SM; Mäntyjärvi R; Syrjänen KJ
Cytopathology; 1994 Oct; 5(5):282-93. PubMed ID: 7819513
[TBL] [Abstract][Full Text] [Related]
32. Functional consequences of directed mutations in human papillomavirus E6 proteins: abrogation of p53-mediated cell cycle arrest correlates with p53 binding and degradation in vitro.
Slebos RJ; Kessis TD; Chen AW; Han SM; Hedrick L; Cho KR
Virology; 1995 Apr; 208(1):111-20. PubMed ID: 11831691
[TBL] [Abstract][Full Text] [Related]
33. Association of p53 codon 72 genotypes and clinical outcome in human papillomavirus-infected lung cancer patients.
Chen SP; Hsu NY; Wu JY; Chen CY; Chou MC; Lee H; Cheng YW
Ann Thorac Surg; 2013 Apr; 95(4):1196-203. PubMed ID: 23522190
[TBL] [Abstract][Full Text] [Related]
34. Detection of human papillomavirus DNA and oncoprotein overexpression are associated with distinct morphological patterns of tonsillar squamous cell carcinoma.
Wilczynski SP; Lin BT; Xie Y; Paz IB
Am J Pathol; 1998 Jan; 152(1):145-56. PubMed ID: 9422532
[TBL] [Abstract][Full Text] [Related]
35. Human papillomavirus infection and p53 alteration in oral squamous cell carcinoma.
Cao J; Zhang ZY; Patima ; Zhang YX; Chen WT
Chin J Dent Res; 2000 Nov; 3(3):44-9. PubMed ID: 11314535
[TBL] [Abstract][Full Text] [Related]
36. Human papillomavirus infection in oral squamous cell carcinomas from Chilean patients.
Reyes M; Rojas-Alcayaga G; Pennacchiotti G; Carrillo D; Muñoz JP; Peña N; Montes R; Lobos N; Aguayo F
Exp Mol Pathol; 2015 Aug; 99(1):95-9. PubMed ID: 26057833
[TBL] [Abstract][Full Text] [Related]
37. Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference.
Jiang M; Milner J
Oncogene; 2002 Sep; 21(39):6041-8. PubMed ID: 12203116
[TBL] [Abstract][Full Text] [Related]
38. Relations between the expression of p53, c-erbB-2, Ki-67 and HPV infection in cervical carcinomas and cervical dysplasias.
Bar JK; Harłozińska A; Sedlaczek P; Kasiak J; Markowska J
Anticancer Res; 2001; 21(2A):1001-6. PubMed ID: 11396132
[TBL] [Abstract][Full Text] [Related]
39. [Prognostic and predictive value of koilocytosis, expression of e6 hpv types 16/18, p16ink4a, p53 in locally advanced squamous cell carcinomas of oral cavity and oropharynx, associated with human papillomavirus].
Riaboshapka AN
Georgian Med News; 2014 Nov; (236):48-55. PubMed ID: 25541826
[TBL] [Abstract][Full Text] [Related]
40. The role of p53 inactivation in human cervical cell carcinoma development.
Miwa K; Miyamoto S; Kato H; Imamura T; Nishida M; Yoshikawa Y; Nagata Y; Wake N
Br J Cancer; 1995 Feb; 71(2):219-26. PubMed ID: 7841033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
